Regeneron Pharmaceuticals, Inc. (REGN) Revenue History
Regeneron Pharmaceuticals, Inc. (REGN) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $4.86B |
| 2017-12-31 | $5.87B |
| 2018-12-31 | $6.71B |
| 2019-12-31 | $6.56B |
| 2020-12-31 | $8.50B |
| 2021-12-31 | $16.07B |
| 2022-12-31 | $12.17B |
| 2023-12-31 | $13.12B |
| 2024-12-31 | $14.20B |
| 2025-12-31 | $14.34B |
How REGN compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| UHS | Universal Health Services Inc. | $17.36B |
| IQV | IQVIA Holdings Inc. | $16.31B |
| VTRS | Viatris Inc. | $14.30B |
| HSIC | Henry Schein Inc. | $13.18B |
| VRTX | Vertex Pharmaceuticals Incorporated | $12.00B |
These are five companies in the same sector as REGN with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Regeneron Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("REGN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | REGN | $807.71 | -0.87% | 0.61M |
| 3 | ||||
| 4 | ||||
| 5 |